Last updated: April 11, 2023
Sponsor: Centre Hospitalier Universitaire de la Réunion
Overall Status: Active - Recruiting
Phase
N/A
Condition
Connective Tissue Diseases
Collagen Vascular Diseases
Musculoskeletal Diseases
Treatment
N/AClinical Study ID
NCT04838574
2021/CHU/03
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients previously included in the RHUMATOCHIK study (N=307), or diagnosed asChikungunya-related Rheumatoid Arthritis (N=21) after telephonic screening and giventheir oral consent
- Chikungunya infection (positive serology and/or evocative symptoms in the epidemiccontext)
Exclusion
Exclusion Criteria:
- Impossible informed consent (cognitive impairment,…).
- Lost-to-follow-up patients, refusal to participate. -Pre-existing chronic inflammatoryrheumatic disease (prior to CHIKV infection)-
Study Design
Total Participants: 220
Study Start date:
February 20, 2023
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
GH Est Réunion
Saint-Benoît,
RéunionSite Not Available
CHU La Réunion (Nord)
Saint-Denis, 97400
RéunionActive - Recruiting
CH Ouest Réunion
Saint-Paul,
RéunionSite Not Available
CHU La Réunion (Sud)
Saint-Pierre, 97448
RéunionActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.